Cancel anytime
MetLife Inc (MET)MET
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/04/2024: MET (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -12.59% | Upturn Advisory Performance 3 | Avg. Invested days: 32 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/04/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -12.59% | Avg. Invested days: 32 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/04/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 59.12B USD |
Price to earnings Ratio 17.39 | 1Y Target Price 91.62 |
Dividends yield (FY) 2.54% | Basic EPS (TTM) 4.91 |
Volume (30-day avg) 3300500 | Beta 1.04 |
52 Weeks Range 61.44 - 89.05 | Updated Date 12/5/2024 |
Company Size Large-Cap Stock | Market Capitalization 59.12B USD | Price to earnings Ratio 17.39 | 1Y Target Price 91.62 |
Dividends yield (FY) 2.54% | Basic EPS (TTM) 4.91 | Volume (30-day avg) 3300500 | Beta 1.04 |
52 Weeks Range 61.44 - 89.05 | Updated Date 12/5/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.27% | Operating Margin (TTM) 15.09% |
Management Effectiveness
Return on Assets (TTM) 0.58% | Return on Equity (TTM) 13.26% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 17.39 | Forward PE 8.75 |
Enterprise Value 73566278659 | Price to Sales(TTM) 0.83 |
Enterprise Value to Revenue 1.04 | Enterprise Value to EBITDA - |
Shares Outstanding 692419968 | Shares Floating 1152409158 |
Percent Insiders 16.41 | Percent Institutions 75.6 |
Trailing PE 17.39 | Forward PE 8.75 | Enterprise Value 73566278659 | Price to Sales(TTM) 0.83 |
Enterprise Value to Revenue 1.04 | Enterprise Value to EBITDA - | Shares Outstanding 692419968 | Shares Floating 1152409158 |
Percent Insiders 16.41 | Percent Institutions 75.6 |
Analyst Ratings
Rating 4.2 | Target Price 78.5 | Buy 5 |
Strong Buy 7 | Hold 2 | Sell 1 |
Strong Sell - |
Rating 4.2 | Target Price 78.5 | Buy 5 | Strong Buy 7 |
Hold 2 | Sell 1 | Strong Sell - |
AI Summarization
MetLife Inc.: A Comprehensive Overview
Company Profile
History and Background:
MetLife Inc. is a leading global provider of insurance, annuities, employee benefits, and asset management. Founded in 1868 as the Metropolitan Life Insurance Company, the company has a rich history spanning over 150 years. Initially focusing on life insurance, MetLife expanded its offerings over time to include annuities, dental, vision, and group insurance products. Today, it operates in over 40 countries and serves over 90 million customers worldwide.
Core Business Areas:
- Life Insurance: MetLife offers a variety of life insurance products, including term life, whole life, and universal life, catering to individuals and families' financial protection needs.
- Annuities: The company provides various annuity products, including fixed, variable, and indexed annuities, helping individuals secure their retirement income.
- Employee Benefits: MetLife offers a comprehensive suite of employee benefit solutions, including group life, disability, dental, and vision insurance, supporting businesses in attracting and retaining talent.
- Asset Management: Through its MetLife Investment Management (MIM) subsidiary, the company provides institutional investors with a range of investment solutions across various asset classes.
Leadership and Structure:
MetLife Inc. is led by CEO Michel Khalaf, who assumed the role in May 2021. The company's leadership team comprises experienced executives with diverse expertise in insurance, finance, and technology. MetLife operates with a decentralized structure, with business units focused on specific product lines and geographic regions.
Top Products and Market Share:
- Term Life Insurance: MetLife is a leading provider of term life insurance in the US, offering competitive rates and flexible coverage options.
- Group Life Insurance: The company holds a significant market share in the US group life insurance market, providing coverage to millions of employees through employer-sponsored plans.
- Annuities: MetLife is a top-five annuity provider in the US, offering a range of products to meet various retirement income needs.
Market Share Comparison:
- Term Life: MetLife holds approximately 10% of the US term life insurance market share.
- Group Life: The company commands roughly 20% of the US group life insurance market share.
- Annuities: MetLife's market share in the US annuity market is approximately 8%.
Competitive Landscape: MetLife faces stiff competition from other major insurance providers like Prudential, AIG, and State Farm in the US market.
Total Addressable Market (TAM):
The global life insurance market is estimated to be worth over $3.5 trillion, with the US market accounting for a significant portion. The US group life insurance market alone represents a sizable opportunity, estimated to be valued at over $150 billion.
Financial Performance:
Recent Financial Performance: MetLife's recent financial performance has been characterized by stable revenue growth, moderate profitability, and consistent dividend payouts.
Revenue: In 2022, the company generated total revenue of $74.3 billion, representing a 2% year-over-year increase.
Profitability: Net income for 2022 reached $7.5 billion, with a net profit margin of 10.1%.
Earnings per Share (EPS): Diluted EPS for 2022 was $7.45, indicating a 3% increase compared to the previous year.
Cash Flow and Balance Sheet: MetLife maintains a healthy cash flow position and a strong balance sheet with ample liquidity.
Dividends and Shareholder Returns:
Dividend History: MetLife has a long history of paying dividends, with a current annual dividend payout ratio of approximately 30%. Shareholder Returns: Over the past year, MetLife's stock has provided a total return of approximately 5%, while its five-year total return is close to 40%.
Growth Trajectory:
MetLife's historical growth has been modest, with revenue increasing at an average annual rate of 3% over the past five years. However, the company projects to accelerate its growth trajectory driven by strategic initiatives, including expanding into new markets and introducing innovative products.
Market Dynamics:
The insurance industry is experiencing several trends, including digitalization, increasing demand for customized insurance solutions, and growing focus on wellness and preventative healthcare. MetLife is actively adapting to these trends by investing in technology, developing data-driven solutions, and expanding its product offerings.
Competitors:
- Prudential Financial (PRU)
- American International Group (AIG)
- State Farm (ticker not publicly traded)
- Northwestern Mutual (ticker not publicly traded)
Market Share Comparison: MetLife's market share varies depending on the specific product and geographic market. However, it ranks among the top competitors in most of its core business areas.
Potential Challenges and Opportunities:
Challenges: MetLife faces potential challenges from economic downturns, rising interest rates, and increasing competition.
Opportunities: Potential opportunities include expansion into emerging markets, developing new partnerships, and introducing innovative insurance products tailored to evolving consumer needs.
Recent Acquisitions (2020-2023):
Brighthouse Financial: In 2020, MetLife completed the separation of its Brighthouse Financial business, creating a leading independent provider of annuities and life insurance.
Versant Health: In 2022, MetLife acquired Versant Health, a leading provider of dental and vision benefits, expanding its employee benefits offering and diversifying its revenue streams.
AI-Based Fundamental Rating:
An AI-based analysis of MetLife's stock fundamentals generates a rating of 7 out of 10. This rating is based on a comprehensive evaluation of the company's financial health, market position, and future prospects. MetLife demonstrates strong financial stability, a well-established brand, and potential for growth in key markets. However, the company's somewhat slower growth trajectory and intense competition could limit its upside potential.
Sources and Disclaimers:
- MetLife Inc. website: https://www.metlife.com/
- U.S. Securities and Exchange Commission (SEC) filings: https://www.sec.gov/edgar/search/
- S&P Global Market Intelligence: https://www.spglobal.com/marketintelligence
Disclaimer: This information is provided for informational purposes only and should not be construed as financial advice. Please consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MetLife Inc
Exchange | NYSE | Headquaters | New York, NY, United States |
IPO Launch date | 2000-04-05 | CEO, President & Director | Mr. Michel Abbas Khalaf |
Sector | Financial Services | Website | https://www.metlife.com |
Industry | Insurance - Life | Full time employees | 45000 |
Headquaters | New York, NY, United States | ||
CEO, President & Director | Mr. Michel Abbas Khalaf | ||
Website | https://www.metlife.com | ||
Website | https://www.metlife.com | ||
Full time employees | 45000 |
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.